Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
-
521
-
522
-
523
-
524
-
525
-
526
-
527
-
528
-
529
-
530
-
531
-
532
-
533
Demonstration of test steps.
Published 2025“…In sand column tests, specimens treated with cementing solution with ferric ion achieved the UCS of 2.83 MPa after five injection cycles, representing a 15-fold increase compared to conventional MICP-treated specimens under the same test conditions. …”
-
534
Anandamide decreases locomotor activity and rearing in small open field.
Published 2016“…<p>Immediately after the rats received anandamide they were placed in the small open field and horizontal (A) and vertical beam breaks (B) were assessed. Pound sign (0.1 mg, # p<0.05), plus signs (1 mg, + p<0.05, ++ p<0.01), and asterisks (10 mg, * p<0.05, ** p<0.01) indicate an increase or decrease in horizontal or vertical beam breaks compared to the vehicle group. …”
-
535
-
536
-
537
-
538
PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
Published 2016“…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
-
539
-
540
Acute JMV2959 treatment decreases alcohol preference in rats.
Published 2013“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”